Browsing: cardiol therapeutics
Amgen (NASDAQ: AMGN) has released positive top-line results from the Phase 3 MINT trial, which evaluated the efficacy and safety…
Explore the fully interactive Multichannel News Release by clicking here: https://www2.multivu.com/amgen/9292951-en-la-la-anthony-amgen-partner-to-encourage-open-dialogue-about-plaque-psoriasis In a recent interactive video, La La provides a…
For a comprehensive and interactive experience, please explore the full Multichannel News Release by clicking on this link: [link to…
Experience the interactive Multichannel News Release in the provided link. The interactive video showcases La La offering a personal and…
Experience the full interactive Multichannel News Release by accessing the following link: https://www2.multivu.com/amgen/9292951-en-la-la-anthony-amgen-partner-to-encourage-open-dialogue-about-plaque-psoriasis. In a newly released interactive video, La…
Cardiol Therapeutics is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies…
Amgen announced the presentation of new data on IMDELLTRA TM (tarlatamab-dlle), a first-in-class delta-like ligand 3 (DLL3)-targeting Bispecific T-cell Engager…
In discussing the complexities of IgA nephropathy, Professor Dana Rizk, an Investigator and APPLAUSE-IgAN Steering Committee Member at the University…
Professor Dana Rizk, an Investigator and member of the APPLAUSE-IgAN Steering Committee, as well as a professor at the University…